Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other ...
The most important variables are structural, not cultural. by Safi Bahcall When I first became a CEO, at age 33, I read everything I could find about legendary business leaders and the companies they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results